TP53 and lung cancer: We provide evidence that the three inherited variations at rs17336602 (G>C), rs4770489 (A>G), and rs34354770 (A>C) in 13q12.12 contribute to the lung cancer risk and development by declining the p53-responsive enhancer-mediated TNFRSF19 activation.